UMN Pharma Inc. | Mutual Funds

Mutual Funds that own UMN Pharma Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
GO UCITS ETF Solutions Plc - DAXglobal Gold Mining Fund
39,643
0.31%
39,643
0.07%
02/28/2018
Siemens Global Growth
36,499
0.28%
1,100
0.09%
04/30/2018
DIAM (Japan) Emerging Market Japanese Equity Fund
0
0%
-21,000
0%
04/17/2017
DIAM (Japan) Hybrid Selection Mother Fund
0
0%
-9,000
0%
02/17/2017
Nomura Asset Nomura DIAM Japanese Equity Mother Fund
0
0%
-9,000
0%
12/12/2016
Meiji Yasuda Asset Japanese Equity Active Portfolio Mother Fd.
0
0%
-6,300
0%
02/15/2017
Fidelity Japan Balanced Mother Fund
0
0%
-7,400
0%
11/30/2016

About UMN Pharma

View Profile
Address
4-2-3 Gosyonoyumoto
Akita Akita 010
Japan
Employees -
Website http://www.umnpharma.com
Updated 07/08/2019
UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, and rotavirus. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan.